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Abstract
Background: The covalently closed-circular DNA (cccDNA) of hepatitis B virus (HBV) is associated with viral
persistence in HBV-infected hepatocytes. However, the regulation of cccDNA and its transcription in the host cells
at different growth stages is not well understood.
Methods: We took advantages of a stably HBV-producing cell line, 1.3ES2, and examine the dynamic changes of
HBV cccDNA, viral transcripts, and viral replication intermediates in different cellular growth stages.
Results: In this study, we showed that cccDNA increased suddenly in the initial proliferation phase of cell growth,
probably attributable to its nuclear replenishment by intracellular nucleocapsids. The amount of cccDNA then
decreased dramatically in the cells during their exponential proliferation similar to the loss of extrachromosomal
plasmid DNA during cell division, after which it accumulated gradually while the host cells grew to confluency. We
found that cccDNA was reduced in dividing cells and could be removed when proliferating cells were subjected to
long term of lamivudine (3TC) treatment. The amounts of viral replicative intermediates were rapidly reduced in
these proliferating cells and were significantly increased after cells reaching confluency. The expression levels of
viral transcripts were increased in parallel with the elevated expression of hepatic transcription factors (HNF4a,
CEBPa, PPARa, etc.) during cell growth confluency. The HBV transcripts were transcribed from both integrated viral
genome and cccDNA, however the transcriptional abilities of cccDNA was less efficient then that from integrated
viral genome in all cell growth stages. We also noted increases in the accumulation of intracellular viral particles
and the secretion of mature virions as the cells reached confluency and ceased to grow.
Conclusions: Based on the dynamics of HBV replication, we propose that HBV replication is modulated differently
in the different stages of cell growth, and can be divided into three phases (initial proliferation phase, exponential
proliferation phase and growth confluency phase) according to the cell growth curve. The regulation of cccDNA in
different cell growth phase and its importance regarding HBV replication are discussed.
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Background
Infection with hepatitis B virus (HBV), which can cause
acute and chronic liver diseases, remains one of the
most serious viral infections in humans. Approximately
400 million people worldwide suffer from chronic hepa-
titis B (CHB) infection, and many of them have a high
risk of developing cirrhosis or hepatocellular carcinoma
[1,2]. In CHB patients, a pool of covalently closed circu-
lar DNA (cccDNA), generated from the relaxed-circle
(RC) form of viral DNA, is maintained in the nuclei of
infected hepatocytes and acts as the template for viral
gene expression [3]. Within infected cells, the prege-
nomic RNA (pgRNA) is transcribed from cccDNA and
reverse transcribed into RC form of viral DNA in the
viral capsids [4]. The mature capsids either are secreted
from the cells or re-enter the nucleus to replenish the
cccDNA pool [5,6].
In addition to its crucial role in HBV life cycle, the
existence of cccDNA interferes with the outcomes of
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(3TC), an antiviral nucleoside analogue which inhibit
viral polymerase activity, effectively inhibits HBV repli-
cation and eliminate the HBV virion from the blood of
patients. However, the cessation of drug treatment
results in the rapid reappearance of HBV in the serum
[7,8]. In vitro studies have shown that the persistence of
cccDNA is responsible for the recurrence of HBV infec-
tion [9]. Several studies have demonstrated that cccDNA
is a very stable molecule. After treatment with antiviral
drugs, the half-life of cccDNA was reported to range
from 33 to 57 days in these hepadnaviruese-infected
woodchucks and ducks [10,11]. Traces of cccDNA per-
sisted indefinitely in the livers of HBV-infected chim-
panzees and provided a continuous antigenic stimulus
that conferred lifelong immunity [12]. Therefore, the
elimination of cccDNA from infected cells, to achieve
viral clearance, has become a major issue in the treat-
ment of chronic HBV infection.
The regulatory mechanisms involved in the clearances
of cccDNA pool are critical, but not well understood,
processes during curing of chronic and acute HBV infec-
tion. It was generally believed that the clearance of
cccDNA is mediated by the cellular immune response
against HBV infection, which acts by: (a) the noncyto-
pathic inhibitory effect of cytokines, which reduce the RC
DNA precursors of cccDNA [13,14]; (b) the cytopathic
effect of the cytotoxic T-lymphocyte (CTL) response,
which destroys the infected hepatocytes; and (c) the dilu-
tion effect achieved with the compensatory proliferation
of the hepatocytes (mitotic loss) [11], which partitions
the cccDNA during cell division [15,16]. Among these,
the antiviral effects of cytokines and CTL have been
extensively investigated. However, the dilution effect and
its relationship with the dynamics of cccDNA pool as
well as HBV replication have not been examined closely.
Several lines of evidence have suggested that HBV
replication is highly dependent on the growth status of
hepatocytes. Clinical specimens show low levels of intra-
hepatic or serum-associated HBV during severe acute
hepatitis at the time of active liver regeneration and
inflammation, which represents a stage of rapid cell
growth [17]. Whereas, high levels of intrahepatic HBV
replication are observed in immunosuppressed patients
or neonates with normal or near-normal hepatic histol-
ogy, in which the hepatocytes remain in the quiescent
stage [18]. Cell-cycle analysis has shown a correlation
between elevated HBV replication and quiescent hepato-
cytes [17,19]. Similar phenomena have also been
observed in an HBV-transfected hepatoblastoma-derived
cell line, which showed increased viral production dur-
ing the cell growth confluency [4,20]. Moreover, HBV
replication and viral mRNA synthesis are significantly
reduced in the proliferative stage [21,22].
In this study, we took advantages of a stably HBV-pro-
ducing cell line, 1.3ES2, to determine the dynamic
changes of HBV cccDNA, viral transcripts, and viral
replication intermediates in different cellular growth
stages. Based on the status of cell proliferation, we pur-
pose a three-phase scenario (initial proliferation phase,
exponential proliferation phase, and growth confluency
phase) to describe the dynamic expression of viral
cccDNA and its association with HBV replication.
Furthermore, our findings also raise the possibility that
facilitating hepatocyte regeneration may interfere with
cccDNA metabolism and contribute to viral elimination.
Methods
Cell culture
The 1.3ES2 cell line is derived from HepG2 cells (a dif-
ferentiated hepatoblastoma cell line) and contains one
integrated copy of the HBV genome [23]. In this study,
the cells were propagated in Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco Laboratories, Grand Island,
NY) supplemented with 10% fetal bovine serum, 100
IU/ml penicillin, 100 μg/ml streptomycin, 2 mM L-glu-
tamine, and 100 μM non-essential amino acid. The cells
were grown at 37°C in a 5% CO2 incubator. In each
experiment, the culture medium was changed every
three days. Lamivudine (3TC) was added to a final con-
centration of 20 μM for the experiment in which 3TC
was used as an inhibitor of HBV replication. A hemocyt-
ometer was used for microscopic cell counts. The cell
samples collected at each time points were appropriately
diluted with GKNP (0.1% glucose, 0.04% KCl, 0.8%
NaCl, 0.006% KH2PO4, 0.01% phenol red, pH 7.4) con-
taining Trypan Blue. All counts were made in triplicate.
Hirt extraction of cccDNA and Southern blot analysis
To isolate cccDNA from 1.3ES2 cells, we used a pre-
viously described procedure, with modifications [23].
The cells with equal cell number were washed twice
with ice-cold GKNP, and the residual washing solution
was then removed as completely as possible. The cells
were lysed by the addition of 3 ml of Hirt solution
(0.6% SDS, 10 mM EDTA, 10 mM Tris-HCl, pH 7.5)
for 5 min. After complete lysis of the cells, 750 μlo f5
M NaCl was added to the cell lysate and mixed gently.
After the whole mixture had been incubated on ice
overnight, the insoluble components were pelleted by
centrifuging at 3, 000 × g for 15 min at 4°C. The super-
natant, which contained the cccDNA, was extracted
twice with phenol and once with phenol-chloroform,
and then precipitated with the addition of two volumes
of absolute ethanol. The precipitates prepared from
equal amount of cells were dissolved with water and
then heated at 85°C for 5 min to denature the DNA.
After EcoRI or XhoI digestion, these DNA samples were
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The agarose gel was soaked twice in denaturing buffer
(0.5 M NaOH, 1.5 M NaCl) for 15 min each and then
neutralized with neutralizing buffer (1.5 M NaCl, 10 M
Tris-HCl, pH 8.0). The DNA samples were then trans-
ferred to nylon membranes Hybond-XL; (Amersham
Pharmacia Biotech, NJ, USA) and UV cross-linked in a
Stratalinker 2400 (Stratagene). The HBV-specific probe
was prepared with the Rediprime™ II Random Prime
Labelling System (Amersham). The membranes were
prehybridized at 65°C for 4 h in HYB-9 DNA hybridiza-
tion solution (Gentra) and then hybridized with the
32P-
radiolabeled DNA probe (2 × 10
8 cpm/μL). After hybri-
dization for 16 h, the membranes were washed three
times (20 min each) with 0.2 × SSC/0.1% SDS at 52°C
and then exposed to X-ray film for 16 h at -80°C.
Protein isolation and Western blot analysis
The cells were harvested for protein isolation in lysis
buffer containing 1% Triton X-100 and the protease
inhibitor Complete (Roche, Mannheim, Germany). The
cell lysate was then centrifuged at 15, 500 × g for 15
min at 4°C, and the supernatant was collected. Total
protein (100 μg) was separated by SDS-15% polyacryla-
mide gel electrophoresis (PAGE) and transferred onto
PVDF membranes (Millipore Corp., Billerica, MA) using
a Trans-Blot Semi-Dry Transfer Cell (Bio-Rad). The
membranes were then blocked with 5% nonfat milk and
probed with anti-HBc antibody (Dako Cytomation,
Glostrup, Denmark) or anti-actin antibody (Sigma, St.
Louis, MO). The immunoblot signals were detected
with enhanced chemiluminescence reagent (PerkinElmer
Life Sciences, Melbourne, Australia).
HBV particle isolation for encapsidated viral genome
analysis
The intracellular HBV core particles were analyzed as
previously described [24,25]. Briefly, equal amounts of
cell lysates were separated on a 1.2% native agarose gel
and transferred onto nylon membrane to detect the cap-
sid-associated nucleic acids. The capsid-associated
nucleic acids were released from the core particles in
situ by treating the membranes with 0.2 N NaOH/1.5 M
NaCl and neutralizing them with 0.2 N Tris-HCl/1.5 M
NaCl. Finally, the membranes were hybridized with
HBV-specific probe.
RNA preparation
The cells were washed twice with cold GKNP. TRIzol
Reagent (Invitrogen) was then added, and the samples
were placed on ice for 10 min to lyse the cells. For each
1 ml of TRIzol Reagent, 200 μl of chloroform was added
and mixed by votexing for 15 s to homogenize the sam-
ples. The samples were centrifuged at 12, 000 rpm at 4°
C for 15 min. Following centrifugation, the aqueous
phase was transferred to a fresh tube, and the RNA was
precipitated by adding 600 μl of isopropanol. The RNA
pellets were collected after centrifugation and then dis-
solved in diethyl-pyrocarbonate-treated water. The RNA
samples were ready for Northern blot analysis or reverse
transcription (RT)-PCR.
Northern blot analysis
Fifteen micrograms of total RNA were resolved electro-
phoretically on a 1.2% agarose gel with 2.2 M formalde-
hyde, followed by upward transfer to a nylon membrane
overnight, and cross-linked under UV. In this experi-
ment, the HBV-specific probe was prepared from the
DNA fragment amplified by PCR using the primer pair
HBV2338/F’ and T20-Taq/HBV5. A hybridization probe
for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was also prepared as the internal control for
normalization. Prehybridization and hybridization were
then performed in HYB-9 DNA hybridization solution
(Gentra). After prehybridization at 65°C for 4 h, the
probe was added and hybridized for 12-6 h. The mem-
brane was washed three times with 1 × SSC/0.1% SDS
buffer at 52°C for 20-30 min each. The RNA was
detected by autoradiography with exposure to X-ray
film for 16 h at -80°C.
Southern blot analysis
Twenty micrograms of total DNA was digested with Hin-
dIII and separated on a 1.2% agarose gel. After electro-
phoresis, the agarose gel was soaked in denaturing buffer
(0.5 M NaOH, 1.5 M NaCl) twice for 15 min each time
and then neutralized with neutralizing buffer (10 M Tris-
HCl [pH 8.0], 1.5 M NaCl). The DNA samples were then
transferred to nylon membranes (Hybond-XL; Amer-
sham Pharmacia Biotech) and UV cross-linked. The
membranes were prehybridized at 42°C for 4 h in prehy-
bridization solution and then hybridized in hybridization
solution with a 32P-radiolabeled DNA probe (2 × 10
8
cpm/μl; prepared using random oligonucleotide priming
of the whole HBV genome). After 16 h of hybridization,
membranes were washed three times (20 min for each
time) with 0.2× SSC and 0.1% SDS at 52°C and then
exposed to X-ray film for 16 h at -80°C.
Cell cycle analysis
Cells were harvested by trypsinization at each time
course. The collected cells were then washed with PBS
followed by 70% ethanol treatment. Finally the cells
were incubated with 100 μg/ml RNaseA and 40 μg/ml
propidium iodide (PI) for 30 minutes just before analysis
by FACS calibur. The software Modfit LT was used to
determine the cell cycle distribution after data
acquisition.
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cDNA templates were generated by the reverse tran-
scription of total mRNA with oligo(dT) 18-mer primer
and SuperScript II reverse transcriptase (Invitrogen),
and then amplified by PCR with the primer pair
HBV2338/F’ and T20-Taq/HBV5. The thermocycling
parameters were 94°C for 1 min; five cycles of 94°C for
30 s, 50°C for 30 s, and 72°C for 30 s; 30 cycles of 94°C
for 30 s, 55°C for 30 s, and 72°C for 30 s; and then a
final extension at 72°C for 10 min. The PCR products
were eluted from the agarose gel after electrophoresis
and subjected to BclI/SspI double digestion. To deter-
mine the relative amounts of the RT-PCR products gen-
erated from the integrated genome or cccDNA, the
restricted samples were separated again by electrophor-
esis on a 2% agarose gel.
Quantification of HBsAg and HBeAg
The HBsAg and HBeAg in the culture medium were
measured with an enzyme-linked immunosorbent assay
( E L I S A )K i tp u r c h a s e df r o mG e n e r a lB i o l o g yC o r pT h e
amount of formazan dye formed correlated with the
amount of HBsAg or HBeAg, which was determined
quantitatively using a scanning multi-well spectrophot-
ometer (ELISA reader) at an absorbance of 450 nm. By
using standards of HBsAg and HBeAg with known con-
centrations, the amounts of the secreted HBsAg and
HBeAg were estimated.
Quantification of the HBV genome
Viral DNA was extracted from the culture media with
the High Pure Viral Nucleic Acid Kit (Roche, Man-
nheim, Germany) according to the manufacturer’s
instructions. A series of dilutions of known concentra-
tions of HBV DNA was used as the control. The stan-
dard curve showed a good linear range when 10
2-10
7
copies of plasmid DNA were used as the templates.
The oligonucleotide sequences of the PCR primers
were: HBV forward 5’-CAGGTCTGTGCCAAGT-3’
and HBV reverse 5’-TGCGGGATAGGACAAC-3’.T h e
PCR products were amplified using the SYBR Green
PCR Master Mix (Roche). The PCR cycling program
consisted of an initial denaturing step at 95°C for 10
min, followed by 45 amplification cycles at 95°C for 12
s and 54°C for 20 s.
Quantitative real-time PCR
The Universal Probe Library was used to quantify the
hepatocyte-specific markers and transcription factors.
The relevant probes were selected from the Universal
Probe Library Set (human), and the corresponding pri-
mers were combined with them. The primer pairs used
in the experiment were: HLF-forward (5’-TTCATCCCT
GATGACCTGAA-3’), HLF-reverse (5’-TGCCATGTTG
TTCTTTCTGC-3’), and probe #61; PPARAa-forward
(5’-GAAGCTGTCCTGGCTCAGAT-3’), PPARAa-
reverse (5’-TCCCCGCAGATTCTACATT-3’), and probe
#14; RXRa-forward (5’-ACATGCAGATGGACAAG
ACG-3’), RXRa-reverse (5’-GAGAGCCCCTTGGAGT-
CAG-3’), and probe #26; NR2F1-forward (5’-ATC
GTGCTGTTCACGTCAGA-3’), NR2F1-reverse (5’-GCT
CCTCACGTACTCCTCCA-3’), and probe #02; NFIL3-
forward (5’-CTCCCCCACTACTGCAAGTC-3’), NFIL3-
reverse (5’-ATCAGTTTCCGACGTTCTCG-3’), and
probe #65; HNF3b-forward (5’-CGTTCCGGGTC
TGAACTG-3’), HNF3b-reverse (5’-ACCGCTCCCAG
CATACTTT-3’), and probe #68; HNF4a-forward (5’-AA
CCTGTTGCAGGAGATGCT-3’), HNF4a-reverse (5’-
CGTTGGTTCCCATATGTTCC-3’), and probe #77;
CEBPa-forward (5’-CAACACTTGTATCTGGCCTCTG-
3’), CEBPa-reverse (5’-CGAGCAAAACCAAAACAAA
AC-3’), and probe #03; HNF1a-forward (5’-TGAGTC
CGGGCTTCACAC-3’), HNF1a-reverse (5’-GGCTGC
TGGAGGACACTG-3’), and probe #42; Alb-forward (5’-
ATGTTGCCAAGCTGCTGATA-3’), Alb-reverse (5’-
CCTTCATCCCGAAGTTCATC-3’), and probe #27;
G6P-forward (5’-GCTGCTCATTTTCCTCATCAA-3’),
G6P-reverse (5’-TTCTGTAACAGCAATGCCTGA-3’),
and probe #67; TAT-forward (5’-TGCTGAGCAGTCT
GTCCACT-3’), TAT-reverse (5’-CTGCTCACAGA
ACTCCTGGAT-3’), and probe #67; and B2M-forward
(5’-TTCTGGCCTGGAGGCTATC-3’), B2M-reverse (5’-
TCAGGAAATTTGACTTTCCATTC-3’), and probe
#42. The real-time PCR was performed using a Roche
machine.
Albumin secretion
The albumin secreted into the medium was measured
with a Human Albumin ELISA Quantitation Kit from
Bethyl Laboratories. Briefly, the culture medium col-
lected at each time point was stored at -20°C until ana-
lysis. The samples were incubated on an ELISA plate
coated with the capture antibody, followed by incuba-
tion with horseradish-peroxidase-conjugated antibody.
Finally, the amount of albumin was measured with a
microtiter plate reader at a wavelength of 450 nm by
detecting the peroxidase activity after the substrate
(TMB) had been added and the reaction stopped with
H2SO4.
Data analysis
Densitometric measurements of band intensities were
made to quantify the proteins/nucleic acids with the
AlphaEaseFC Imaging System software version 6.0.0
(Alpha Innotech Corp.). In all cases, the samples col-
lected at the first time point were deemed to be 100%.
All statistical analyses were performed with Student’s t
test.
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Dynamics of HBV replication during cell proliferation and
growth confluency
To explore the dynamics of HBV replication at different
cell growth stages, the confluent 1.3ES2 cells (grown for
12 days) were re-plated to initiate cell growth and then
continuously cultured for 24 days. The cell numbers
and the HBV replication profiles were determined by
three-day-intervals. According to the cell proliferation
status, the cell growth curve was divided into three
phases including (I) initial proliferation phase, (II) expo-
nential proliferation phase, and (III) growth confluency
phase (Figure 1A). To examine the correlation between
HBV replication and cell growth stages more closely, a
series of HBV replication categories, including intracel-
lular viral events and secreted viral products, were ana-
lyzed (Figure 1B-H). A gradual increase of viral
transcripts (Figure 1B) and intracellular HBc (Figure 1C)
were observed in both proliferating cells (days 3-6) and
confluent cells (days 12-24). Since the viral nucleocapsid
is composed of pgRNA and viral core protein [5], we
examined the formation of intracellular viral nucleocap-
sids in different cell growth stages by particle blot analy-
sis (Figure 1D). The increased intensity of the
encapsidated viral genome indicated the dramatic for-
mation of intracellular viral nucleocapsids when cells
were grown to confluence (Figure 1D, days 12-24). It
has been well characterized that the intracellular viral
nucleocapsids would either enter the nucleus to convert
into viral cccDNA or secrete out of the cells [5,6]. Thus,
we collected the Hirt extracts and culture media at var-
ious time points to analyze their viral contents (Figure
1E-H). After restriction enzyme digestion, the nature of
viral cccDNA was revealed by the observation of band
shift from 1.5 kb (uncut) to 3.2 kb (EcoRI or XhoI) (Fig-
ure 1E). Similar to the increase of intracellular viral par-
ticles in the confluent cells, the amount of cccDNA and
the secreted viral products (HBe/cAg, HBsAg, and
mature virion) were increased slowly as cells were
grown to confluence (Figure 1E-H, days 9-24). However,
the expression levels of cccDNA and secreted viral com-
ponents in the proliferation stages were not coincidental
with that of intracellular viral products. For example,
the amount of cccDNA and the secreted viral products
(HBe/cAg, HBsAg, and mature virion) were significantly
elevated in the initial proliferation phase (Figure 1E-H,
days 0-3) and then severely reduced in the exponential
proliferation phase (Figure 1E-H, days 3-6). In contrast,
the intracellular viral replications (viral transcripts, intra-
cellular HBcAg, and intracellular viral capsids) were
relatively less in the initial proliferation stage (Figure
1B-D, day 3) and were gradually increased during the
exponential proliferation and the growth confluence
stages (Figure 1B-D, days 6-24). To further clarify the
HBV replication in different cell cycle phases of 1.3ES2
cells, the cell cycle distribution at indicated time points
were analyzed (Figure 1I). By using FACS analysis, we
dissected the cell populations of 1.3ES2 cells which were
initially with 54% of G0/G1 phase and 37% of S phase at
day 3. However, once reaching confluence, the cells
were arrested at G0/G1 phase (77-87%) in together with
reduction in S phase (5-9%) (Figure 1I, day 12-24). In
recording the cell numbersb yt r y p a nb l u ee x c l u s i o n
method, we noticed that there was no significant
increase in cell number after confluence (Figure 1A, day
12-24).
The dynamic changes of HBV transcripts, intracellular
viral DNA and cccDNA expression profiles during cell
proliferation and growth confluency
Because the maintenance of HBV cccDNA in hepatocytes
plays a key role in viral persistence and reactivation, it is
important to understand the dynamics of HBV cccDNA
expression in terms of cell growth stages. To obtain a
clear picture how HBV replication affects cccDNA accu-
mulation, the dynamics of HBV transcripts and viral
DNA replicative intermediates were examined more pre-
cisely, especially during the initial proliferation phase and
the exponential proliferation phase (Figure 2). The
expression of HBV transcripts (3.5 kb, 2.4 kb and 2.1 kb)
were gradually increased during cell proliferation and cell
growth confluency (Figure 1B and 2A). In parallel to the
slow increase of HBV transcripts, the expressions of viral
relaxed-circular (RC) and duplex-linear (DL) form DNAs
were significantly reduced in the initial proliferation
phase, followed by gradually increased in the exponential
proliferation phase and dramatically elevated in the
growth confluency phase (Figure 2B). Since the RC DNA
is the precursor of cccDNA, we next examined the
expression profiles of cccDNA in different cell growth
stages. As mentioned above, we found that there was a
sudden increase in the cccDNA content of the cells dur-
ing the initial proliferation phase (Figure 2C, days 0-3).
When the cells underwent rapid proliferation in the
exponential phase, the levels of cccDNA decreased signif-
icantly (Figure 2C, days 4-8). After that, the amount of
cccDNA increased again gradually when the cells ceased
to grow in the confluent phase (Figure 2C, days 9- 24).
Interestingly, the expressions of ssDNA (single-stranded
DNA derived from the protein-free DNA species by arti-
ficial heat denaturation) and intracellular viral DNA (RC
DNA and DL DNA), were inversely proportional to the
elevation of cccDNA in the initial proliferation phase
(Figure 2B-C, days 0-3) but was strongly coordinated
with the accumulation of cccDNA in the growth con-
fluency phase (Figure 2B-C, days 9-24).
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producing 1.3ES2 cell line
Because cccDNA decreased rapidly during the exponen-
tial phase of cell growth (Figure 2C, days 4-8), we
anticipated that rapid cell dividing may help to metabo-
lize pre-existing cccDNA pool. To examine the half-life
of HBV cccDNA in different cell growth phases, lamivu-
dine (3TC) was used to inhibit HBV replication and to
Figure 1 HBV replication profiles in 1.3ES2 cells growing from proliferation to confluence. 1.3ES2 cells (2.5 × 10
6) were initially plated
onto a 6 cm diameter Petri dish and cultured continuously for 24 days. The culture medium was refreshed every three days during the
experimental period. (A) The cell number profiles were determined with the Trypan Blue exclusive method at the indicated time points. (B) Total
RNA was extracted for Northern blot analysis and the expression profiles of HBV transcripts were determined. A GAPDH-specific probe was used
to control for equal sample loading. (C) Cell lysates (100 μg) collected at the indicated time points were subjected to Western blot analysis for
the detections of HBcAg and b-actin. (D) Equal amounts of cell lysates were subjected to native agarose gel electrophoresis for particle blot
analysis. The encapsidated viral genomes were quantified by using an HBV-specific probe. (E) The intracellular cccDNA was collected by Hirt
extraction at each time point. The cccDNA from equal amounts of cells was thermally denatured and then subjected to restriction enzyme
digestion before electrophoresis and Southern blot analysis. The ssDNA represents the single-stranded viral DNA derived from the protein-free
RC DNA by artificial heat denaturation. (F) The culture medium was collected at the indicated time points and the amounts of secreted HBeAg
were determined by ELISA. (G) HBsAg production in the culture medium at each time point was analyzed by ELISA. (H) The secreted viruses
were purified from the collected culture media, and the HBV titers were determined with quantitative RT-PCR analysis. (I) These growing cells
were analyzed by FACS caliber at each time points and the cell cycle distributions were represented. Each time point represents the mean ± SD
of triplicate experiments.
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phases. 1.3ES2 cells (2.5 × 10
6) were initially plated onto a 10 cm diameter Petri dish and cultured continuously for 24 days. The culture
medium was refreshed every three days during the experimental period. (A) Total RNA was extracted at the indicated time points and subjected
to Northern blot analysis to determine the expression profiles of the 3.5-kb, 2.4-kb, and 2.1-kb HBV transcripts. A GAPDH-specific probe was used
to control for equal sample loading. (B) Total DNA was extracted at the indicated time points, digested with HindIII, and then separated by
electrophoresis. The expression profiles of the integrated viral genome, RC DNA, and DL DNA were examined by Southern blot analysis. The
integrated viral genome was used to control for equal sample loading. (C) The intracellular cccDNA was collected by Hirt extraction at each time
point. The cccDNA was thermally denatured at 85°C for 5 min, and then subjected to EcoRI digestion before electrophoresis on a 1.2% agarose
gel and Southern blot analysis.
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1.3ES2 cells. 3TC was added to the cells at two different
time points after plating: one culture was treated with
3TC the day after the cells were reseeded, during the
initial proliferation stage (Figure 3A-B), and another cul-
ture was treated with 3TC on day 12 after the cells were
reseeded, when the cells were grown in the confluence
phase (Figure 3C-D). Both groups of samples were col-
lected every three days in the presence of 3TC, and the
expression of cccDNA was measured by Southern blot
analysis. The initial amounts of cccDNA in the two dif-
ferent groups were almost equal at the moment when
3TC was added (Fig, 3B, day 0; and Figure 3D, day 12),
but their kinetics of cccDNA metabolism were quite dif-
ferent after prolonged 3TC treatment. We found that
the half-lives of cccDNA measured in the rapidly grow-
ing cells and in the stationary cells were different. In the
exponentially proliferating cells, the half-life of cccDNA
was about five days, and it then became undetectable on
Southern blots within nine days (Figure 3B). However,
once the cells had grown to confluence, the half-life of
cccDNA was about nine days, and the remaining 20% of
the cccDNA was retained stably inside the cells for
more than 30 days (Figure 3D). It suggests that the
Figure 3 Determination of the half-life of cccDNA in different growth stages. (A) and (B) show the cell growth curve and cccDNA
expression profile in the proliferating 1.3ES2 cells. The growth confluent cells were reseeded to initiate their proliferation, and 3TC was added at
the day after plating. (A) The cell numbers were determined with the Trypan Blue exclusive method at the indicated time points. (B) The
cccDNA before and after 3TC treatment was collected by Hirt extraction at each time point. The cccDNA was thermally denatured at 85°C for 5
min, then subjected to EcoRI digestion before electrophoresis on a 1.2% agarose gel and analyzed by Southern blot analysis. (C) and (D) show
the cell growth curve and cccDNA expression profile in the confluent cells. After continuous culture for 12 days, the confluent cells were treated
directly with 3TC from day 12 to day 42. (C) The cells numbers were determined with the Trypan Blue exclusive method at the indicated time
points. (D) The Hirt extracts for each time point were thermally denatured at 85°C for 5 min, then subjected to EcoRI digestion before
electrophoresis on a 1.2% agarose gel and analyzed by Southern blot analysis. The line charts represent the relative quantitative intensities of the
cccDNA from each experiment.
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Page 8 of 16treatment of proliferating cells, but not growth confluent
cells, with 3TC has the potential to remove cccDNA
from HBV-producing cells.
The evaluation of transcriptional efficiency of HBV
cccDNA during cells growth from proliferation to
confluency
Our previous studies had shown that 1.3ES2 cells con-
tain a single integrated copy of the HBV genome and an
average of 4-6 copies of cccDNA per cell at day 3, all of
which can act as templates for viral transcription [23].
Because 1.3ES2 cells contain the BclI restriction site in
the 3’ terminal redundancy of the HBV genome, we can
distinguish the two populations of viral transcripts sim-
p l yb yR T - P C Rc o m b i n e dw i t hSspI/BclId i g e s t i o n[ 2 3 ] .
Briefly, the HBV transcripts were first amplified by RT-
PCR with an HBV-specific primer pair (HBV2338/F and
T20-Taq/HBV5), and the 935-bp PCR product was then
subjected to SspI/BclI double digestion. The resulting
amounts of the 132-bp and 200-bp DNA fragments
were proportional to the amount of mRNA derived
from the integrated genome. In contrast, the amount of
the 332-bp PCR fragment after SspI/BclI double diges-
tion was proportional to the mRNA derived from
cccDNA (Figure 4A). Equal amounts of total RNA
extracted at different time points were analyzed by RT-
PCR and subsequent SspI/BclI double digestion (Figure
4C). As the cells grew to confluence, the transcripts
from the cccDNA (332-bp fragment) and from the inte-
grated viral genome (132-bp and 200-bp fragments)
both gradually increased (Figure 4C), which is consistent
with our previous observations with Northern blot ana-
lysis (Figure 1B and 2A). Even though the transcripts
from cccDNA were relatively less, the elevation of tran-
scripts from cccDNA was significantly more efficient
than that from the integrated viral genome (Figure 4C,
right panel). To further confirm our observation, the
proportions of HBV transcripts from the two transcrip-
tional origins were monitored by using equal amounts
of HBV RT-PCR products (as demonstrated by the
same intensity of 603-bp signals) (Figure 4D). The pro-
portion of transcripts from the cccDNA was lower than
that from the integrated genome, which accounted for
less than 10% of the total viral transcripts on day 6 (Fig-
ure 4D). However, the proportion of transcripts from
the cccDNA was increased significantly once the cells
reached confluence (Figure 4D, days 12-24). Interest-
ingly, the increase in transcripts derived from the
cccDNA was proportional to the increase of cccDNA
during cell growth from proliferation to confluence (Fig-
ure 4B and 4D, right panels). Meanwhile, the proportion
of transcripts from the integrated viral genome
remained almost constant during cell growth (Figure
4D, right panel).
Expression of transcription factors and differentiation
markers in long-term cultures of stably HBV-producing
cells
Despite the constant amount of integrated viral genome
within the cells, the transcripts from the integrated HBV
genome (132-bp and 200-bp fragments) increased gra-
dually during cell growth to confluence (Figure 4C).
This indicates that the transcription efficiency of the
HBV transcripts from the integrated viral genome is
enhanced during cell growth from proliferation to con-
fluency. Therefore, we next examined the expression
profiles of hepatic transcription factors during long-term
cell growth. Because many cellular transcription factors
are reported to regulate HBV transcription [26], the
expression profiles of these transcription factors in con-
tinuously cultured cells were investigated. Total RNA
was extracted at various time points, and the expression
profiles of the viral transcripts during cell growth were
examined for reference (Figure 5A). Quantitative RT-
PCR analysis demonstrated that the expressions of sev-
eral well-known positive regulators of HBV transcrip-
tion, including HNF4a,C E B P a, PPARa and HLF, were
elevated in long term cultured cells (Figure 5B). Simulta-
neously, the expression of HNF1a and RXRa remained
unchanged during that period. These changes in the
expression pattern of hepatic transcription factors might
contribute, at least in part, to the consequence of tran-
scriptional up-regulation of HBV replication during cell
growth to confluence. However, we do not exclude the
possibility that such an expression profile changes of
these transcription factors during cell growth might be
specific to the cell line we used.
It has been suggested that the expression of these
hepatic transcription factors coordinately regulates hepa-
tocyte differentiation [27-30] and that cellular differen-
tiation is usually preceded by cell growth arrest
[19,31-33]. Therefore, we analyzed the expression of
hepatocyte-specific differentiation markers by quantita-
tive RT-PCR and examined their correlation with cell
growth phases. The expression of albumin, tyrosine ami-
notransferase (TAT), and glucose-6-phosphatase (G6P)
was up-regulated when the cells became confluent (Fig-
ure 5C). The culture medium was collected to deter-
mine the cellular albumin secretion. Consistent with the
elevated levels of albumin transcriptions, the amount of
secreted albumin increased progressively during cell
growth to confluence (Figure 5D).
Discussion
Dynamics of HBV replication in three different cell growth
phases
In summary, we present here a three-phase model to
describe the different phenomena involved in HBV
replication (Figure 6). Based on the proliferation statuses
Chong et al. Journal of Biomedical Science 2011, 18:96
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Page 9 of 16Figure 4 Transcription profiles of HBV pgRNA during cell growth to confluence. (A) Schematic representation of the strategy for detection
of origins of viral transcripts. 1.3ES2 cells contain a 1.3-fold HBV genome with the BclI genetic marker in the 3’ terminus redundancy. Viral
transcripts from the integrated genome generate a BclI marker within the 3’ terminus redundancy region, while transcripts derived from cccDNA
does not. After RT-PCR (with primers HBV2338/F and T20-Taq/HBV5) and restriction enzyme digestion with SspI and BclI, the restricted PCR
products are separated by agarose gel electrophoresis. The existence of 332-bp product, which lacks the BclI site, represents transcripts from
cccDNA, whereas the two fragments of 200-bp and 132-bp represent transcripts from the integrated genome. (B) The cccDNA was collected
with the Hirt extraction method at each time point, thermally denatured at 85°C for 5 min, and then subjected to EcoRI digestion before
electrophoresis on a 1.2% agarose gel. All the lanes were loaded with samples representing the same numbers of cells. The autoradiograph
shows the cccDNA and ssDNA; the line chart shows the relative quantitative intensities of the cccDNA. (C) Equal amounts of total RNA from
each sample were used for RT-PCR with the primer pair HBV2338/F and T20-Taq/HBV5. Following SspI/BclI double digestion, the restricted PCR
products were separated by electrophoresis. The relative quantitative intensities of the PCR products are shown in the line chart: 332-bp (–●–),
200-bp and 132-bp (...○...), and 603-bp (–▼–). (D) Equal amounts of the HBV RT-PCR products, amplified by the primer pair HBV2338/F and T20-
Taq/HBV5, were subjected to SspI/BclI double digestion, and the restricted PCR products were separated by electrophoresis. The relative
quantitative intensities of the PCR products are shown in the line chart: 332-bp (–●–), 200-bp and 132-bp (...○...).
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Page 10 of 16of HBV-producing cells, we discuss the replication of
HBV by three different cell growth phases: (I) initial
proliferation phase, (II) exponential proliferation phase,
and (III) growth confluency phase (Figure 2). We found
that the dynamics of HBV transcripts expression, intra-
cellular viral DNA (RC and DL DNA), and cccDNA
profiles were quite different in these three growth
phases. For example, the amount of HBV transcripts
was relatively low in both the initial and exponential
proliferation phases, but was significantly increased
when the cells ceased to grow during confluence (Figure
2A). On the other hand, the amount of intracellular
viral DNA was relatively high at the beginning of prolif-
eration (Figure 2B, day 0), and then significantly
decreased in the initial proliferation phase (Figure 2B
days 0-3). After that, the levels of viral RC and DL DNA
were gradually increased during exponential prolifera-
tion phase (Figure 2B, days 4-8) and dramatically accu-
mulated in the cell growth confluency phase (Figure 2B,
days 9-24). In contrast, a dramatic increase of HBV
cccDNA pool was observed in the end of initial
proliferation phase (Figure 2C, day 3), followed by a
severe drop in cccDNA amount once cells were expo-
nentially growing (Figure 2C, day 4). The amount of
cccDNA maintained at a relatively lower level in the
exponential proliferation stage and then accumulated
progressively after growth confluency. The detail
mechanisms of these inconsistent phenomena were
further discussed below.
The correlation between cell cycle phases and cccDNA
accumulation
There are two previous achieves on studying the rela-
tionship between cell cycle phases and cccDNA accu-
mulation [34,35]. By using different cell cycle blocker
(Aphidicolin or n-Butyrate), both groups examined the
expression level of cccDNA in the cells of G1 arrest, but
their studies led to completely conflicting conclusions.
The inconsistency might caused by their different model
systems (HBV-produced HepG2 cell line vs. In Vitro
infection of duck hepatocyte cultures), using different
G1 blockers (Aphidicolin vs. n-Butyrate), or different
Figure 5 Expression levels of transcription factors associated with the regulation of HBV transcription. (A) Total RNA was extracted at
the same time points and subjected to Northern blot analysis to determine the expression profiles of the HBV transcripts: the 3.5-kb, 2.4-kb, and
2.1-kb transcripts (upper panel). The amount of sample loaded was normalized with a GAPDH-specific probe (lower panel). (B) The expression of
transcription factors that regulate HBV pgRNA transcription was assessed by quantitative real-time RT-PCR at the indicated time points. The bar
chart shows the relative expression of HNF4a, HNF1a, HNF3b, CEBPa, PPARa, RXRa, HLF, NR2F1, and NFIL3 mRNAs which was normalized to
that of B2M. ■ day 3 sample; ■ day 6 sample; ■ day 9 sample; ■ day 12 sample. * P < 0.05, ** P < 0.01, and *** P < 0.001. The data were
analyzed statistically with Student’s t test. (C) The expression profiles of hepatocyte-specific markers (albumin, TAT, G6P mRNAs) were determined
by real-time RT-PCR. The results are shown after normalization to B2M. ■ day 3 sample; ■ day 6 sample; ■ day 9 sample; ■ day 12 sample. (D)
The culture media were collected at the indicated time points, and the amounts of secreted albumin were determined by ELISA.
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Page 11 of 16Figure 6 Illustration of the three growth-stage model ofr HBV replication in 1.3ES2 cells. The growth curve of HBV can be separated into
three phases: (I) the initial proliferation phase; (II) the exponential proliferation phase; and (III) the growth confluency phase. In the initial
proliferation phase, the increase in cccDNA replenishment in the nucleus during the initial cellular proliferation generates a dramatic increase in
HBV cccDNA inside the cells. The increased secretion of HBV capsids and low levels of cellular transcription factors explain the relative inactive
HBV replication and the inefficient viral transcription inside the cells. In the exponential proliferation phase, the cccDNA decreases significantly,
probably because of the dilution effect caused by cell division. The viral transcripts and intracellular nucleocapsids gradually increase in this
stage. In the growth confluency phase, HBV transcription dramatically elevates with the increase in cellular transcription factors as the cells reach
confluence. Meanwhile, the gradual accumulation of cccDNA and intracellular viral particles, together with elevated viral secretion are observed
in these confluent cells.
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Page 12 of 16experimental designs used by these two groups. Our
results showed that the accumulation of cccDNA was
parallel with G1 arrest when cells were grown to con-
flurence (Figure 1A, E, and 1I), which is consistent with
the previous report done by Yeh CT et al. [34]. They
demonstrated that viral RC-DNA imported into nuclear
at the G1 phase and cccDNA accumulated after pro-
longed treatment of Aphidicolin (a G1 blocker). Differ-
e n tf r o mt h e i rs t r a t e g y ,w ek e p tc u l t u r i n g1 . 3 E S 2c e l l s
for 12 days (cell growth confluence) before re-plating
instead of synchronization of these cells by serum star-
vation. Thus, large amounts of RC-DNA accumulated
by 12 days of culture would serve as the source of
cccDNA, once cells begin their initial proliferation after
re-plating. However, our results also showed that the
increase of cccDNA pool in the initial proliferation
stage was not correlated to its G1 phase. This conflict-
ing result indicated that the accumulation of cccDNA is
not simply laid on the cell cycle phase (such as G1
arrest) and other parameter might also involve in the
modulation of cccDNA pool. For example, as observed
in the initial proliferation stage, large amount of pro-
tein-free RC-DNA and slower cell dividing rate might
contribute, at least in part, to its conversion of RC-DNA
to cccDNA. Consequently, we observed that the increase
of cccDNA was accompanied with the decrease of pro-
tein-free viral DNA (ssDNA) in this stage (from day 0
to day 3). Moreover, we found that the cccDNA pool
was dramatically reduced in the exponential prolifera-
tion stage (from day 3 to day 9), which is consistent
with the findings (by Yeh CT et al. [34]) that a rapidly
g r o w i n gc e l lc u l t u r ep o s s i b l yd i dn o th a v eaG 1p h a s e
long enough for supporting the conversion of RC-DNA
to cccDNA.
The dynamic expression of HBV transcripts and its
regulation in different cell growth phase
As mentioned before, both integrated HBV genome and
cccDNA molecule are able to serve as origins of HBV
transcripts [23]. However, the integrated HBV genome
and the dynamic changes in cccDNA amount could
only partially explain the gradual elevation of viral tran-
scripts during cell growth. For example, in the growth
confluency phase, cccDNA progressively accumulated
inside the nucleus, providing increased templates for
the transcription of viral mRNA. Indeed, the proportion
of transcripts from cccDNA perfectly matched the
kinetics of cccDNA accumulation during cell growth
(Figure 4B and 4D, right panels). Nevertheless, the
amount of cccDNA is not the only parameter involved
in the elevation of viral mRNA expression. Our study
revealed that the elevation of hepatic transcription fac-
tors might also contribute to the activation of HBV
transcription. In the initial proliferating cells, we
observed that the relatively lower amount of hepatic
transcription factors paralleled the inefficient synthesis
of viral transcripts even with a large amount of cccDNA
in this stage (Figure 2A, C and 5B, day 3). In contrast,
the expression levels of several hepatic transcription fac-
tors were elevated in the growth confluency phase (Fig-
ure 5B). Among these, HNF4a, PPARa,C / E B P a,a n d
HLF have been suggested to function as positive regula-
tors of HBV replication. For example, HNF4a and
RXRa/PPARa have been shown to support HBV
pgRNA synthesis and viral biosynthesis in nonhepatic
cells [26,36]. C/EBPa, together with HBx, has been
reported to enhance the HBV pregenomic promoter
synergistically in hepatocytes [37]. HLF also exerts a sti-
mulatory effect on the HBV promoter and strongly sti-
mulates the synthesis of pgRNA [38]. Taken together,
these elevated hepatic transcription factors might coor-
dinate with the accumulated cccDNA and comprehen-
sively enhance HBV transcription efficiency as the cells
gradually ceased to grow (Figure 4C, right panel). In
conclusion, our data suggest that the transcriptional
regulation of HBV is tightly controlled by the dynamic
changes in cccDNA and cellular transcription factors
during cell growth. Moreover, our results also showed
the coordinately enhanced differentiation of 1.3ES2 cells
as cells were grown to confluence (Figure 5C-D). The
differentiation status of the hepatocytes paralleled the
elevation of several hepatocyte-enriched transcription
factors, which might stimulate viral transcription and
enhance HBV replication. These findings were coinci-
dent with previous reports which showed a positive cor-
relation between cell differentiation status and viral
replication [39,40].
Kinetic expression of intracellular DNA in different cell
growth phases
The high intensity of viral RC and DL DNA in the
beginning of initial proliferation stage indicated that
large amount of intracellular nucleocapsids was accumu-
lated before cell re-plating. However, once these cells
started to proliferate, the intensity of intracellular viral
DNA was gradually decreased (Figure 2B, days 0-3).
Similar phenomena were found by tracing the dynamic
expression of protein-free viral DNA (ssDNA), the pre-
sumed precursor of cccDNA [41] (Figure 2C, days 0-3).
Meanwhile, a dramatic increase of HBV cccDNA pool
was observed (Figure 2C, days 0-3), which suggested
that the intracellular nucleocapsids were replenished
into the nucleus and the embedded viral DNAs were
converted to cccDNA in this stage. Coincident with the
significant increase of HBV transcripts, the intracellular
nucleocapsids (as revealed by the signals of RC and DL
DNA) were dramatically elevated when these cells were
grown to confluence (Figure 2B, days 9-24).
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Page 13 of 16Dynamic expression of cccDNA in different cell growth
phases
As mentioned above, the sudden increase of cccDNA
was accompanied with a reduction of intracellular
nucleocapsids when the host cells underwent their initial
proliferation (Figure 2B-C, days 0-3). It seems that the
disappearance of the nuclear membrane during mitosis
facilitated the entry of pre-existing intracellular nucleo-
capsids into the nucleus, and the released protein-free
RC DNA was consequently converted to cccDNA in the
initial proliferation stage. However, once cells entered
the exponential phase, the amount of cccDNA was
declined dramatically (Figure 2C, days 4-8). Because the
cccDNA lacks a replication origin, the reduction of
cccDNA in the rapidly proliferating cells might be
caused by a dilution effect similar to the loss of extra-
chromosomal plasmid DNA during cell division [42,43].
After the cells reached confluence and ceased to grow,
the intracellular nucleocapsids and protein-free viral
DNA (ssDNA) accumulated markedly (Figure 2B-C,
days 9-24), which could account for the gradual replen-
ishment of cccDNA in the growth confluency phase.
This observation is consistent with the previous report
in which the HBV cccDNA formation in cultured cells
is accompanied by the accumulation of protein-free viral
DNA species [41].
The evaluation of viral transcriptional efficiency during
cells growth to confluence
To evaluate the transcriptional efficiency of cccDNA in
different cell growth phase, we carried out the RT-PCR
combined with the restriction enzyme digestion assay
[23]. We found that the transcriptional ability of
cccDNA was less efficient then that from integrated
viral genome in all cell growth stages (Figure 4C, left
panel). By comparing the relative intensities of PCR
fragment from cccDNA (332-bp) and these from inte-
grated viral genome (200-bp and 132-bp), the estimated
proportion of transcripts from cccDNA relative to the
amount from the integrated HBV genome was only 5%
to 20% (Figure 4D and data not shown). However, the
detail mechanism how transcription regulators manipu-
late the differential transcription efficiencies of cccDNA
and integrated viral genome is not clarified yet. In spite
of the lower amount of transcripts from cccDNA, the
elevating potency of transcription from cccDNA was
significantly raised during cell growth as compared with
that from integrated viral genome (Figure 4C, right
panel). To clarify precisely the proportions of transcripts
from these two origins during cells growth to conflu-
ence, equal amounts of RT-PCR products were used to
examine their transcriptional origins (Figure 4D). Inter-
estingly, the proportional change of transcripts from
cccDNA (Figure 4D, right panel) completely paralleled
with the dynamic expression of cccDNA during cell
growth (Figure 4B, right panel). In the meanwhile the
proportion of transcripts from integrated genome
remained constant (Figure 4D, right panel). It indicates
that the higher elevation potency of transcription by
cccDNA was resulted from the increase of cccDNA pool
within the cells when cells were grown to confluence.
Modulation of cccDNA metabolism by cell proliferation
The amount of cccDNA was estimated to be approxi-
mately 4-6 copies of HBV cccDNA per cell on day 3
[23]. During exponential proliferation, the cccDNA
decreased rapidly to less than 0.4-0.6 copies per cell.
Thereafter, the number of cccDNA copies per cell accu-
mulated continuously during cell growth to confluence
(Figure 4B). The constant presence of cccDNA in the
hepatocyte is generally considered to play critical roles
in the HBV life cycle, including in viral replication, per-
sistent infection, and recurrence. cccDNA also functions
as a risk marker for the development of hepatocellular
carcinoma because hepatocarcinoma tissue is reported
to have higher levels of cccDNA than non-tumor tissues
[44]. Therefore, the eradication of cccDNA from
infected hepatocytes is considered to be the therapeutic
goal for viral clearance in CHB patients. With lamivu-
dine (3TC) treatment, we blocked the formation of
newly synthesized cccDNA and determined the half-life
of cccDNA in both proliferating cells and growth con-
fluent cells (Figure 3). We found that the cccDNA mole-
cule is extremely stable in the confluent cells, which still
retained a constant amount of cccDNA after prolonged
treatment with 3TC for 30 days (Figure 3D). This
observed longevity of cccDNA is consistent with pre-
vious reports that cccDNA is a very stable molecule
[10,11]. Surprisingly, we found that cccDNA was drama-
tically reduced in the proliferating cells (Figure 3B).
Without replenishment of cccDNA, the pre-existing
cccDNA pool was dramatically diluted by rapid cell divi-
sion. Moreover, the trace of cccDNA became undetect-
able by treating proliferating cells with 3TC for 9 days
(Figure 3B). It suggests that the half-life of cccDNA is
reduced and that the molecule is relatively unstable in
proliferating cells. Several lines of evidence confirm our
finding that cell division efficiently dilutes the amount
of cccDNA in infected hepatocytes. For instance, in con-
genitally DHBV-infected hepatocyte cultures, the half-
life of the DHBV cccDNA was estimated to be only 3-5
days in continuously proliferating cells, which confirms
the loss of cccDNA during cell division [45]. Similarly, a
kinetic study of WHV loss after treatment with an anti-
viral agent suggested that the reduction in cccDNA
might have been caused by its redistribution to the
daughter cells of the infected hepatocytes [10]. More-
over, an in vitro proliferation study of HBV-infected
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Page 14 of 16hepatocytes showed that cell division plays a crucial role
in cccDNA clearance in the chronically infected hepato-
cytes [16]. Because the elimination of cccDNA is essen-
tial for HBV clearance, our study provides the notion
that the combination of treatment with an antiviral
agent and the induction of cell proliferation, such as
limited inflammation or partial hepatectomy, might
accelerate cccDNA metabolism and facilitate viral
clearance.
Conclusions
In this study, the dynamic changes of HBV cccDNA,
viral transcripts, and viral replication intermediates in
different cell growth stages were well investigated. Our
study elucidated how the growth status of hepatocytes
affects the formation of cccDNA. A three-phase scenario
(initial proliferation phase, exponential proliferation
phase, and growth confluency phase) describing the
dynamic expression of viral cccDNA and its association
with HBV replication was proposed. Moreover, we
found that the half-life of cccDNA is reduced in dividing
cells treated with lamivudine (3TC), and the cccDNA
molecule could be completely removed by long-term
treatment of 3TC. The significance of our findings
regarding HBV regulation in CHB patients was
discussed.
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